Gene Therapy/AAV

Navigating AAV Vector Biodistribution Analysis and Transgene Expression Using RNAscope™ in situ Hybridization Technology

The RNAscope ISH technology is an ideal solution for detecting AAV vector DNA and therapeutic transgene mRNA expression with morphological context, addressing critical questions on tissue biodistribution, cellular tropism, and vector performance in vivo. Screen for transduction efficiency of capsid or vectors designed to escape the immune response.

 

FDA strongly recommends biodistribution studies to characterize engineered products (1). RNAscope in situ hybridization assay is the most powerful spatial method available within the methods provided.

 

(1) S12 Nonclinical Biodistribution Considerations for Gene Therapy Products; Guidance for Industry; U.S. Department of Health and Human Services Food and Drug Administration; Center for Drug Evaluation and Research (CDER); Center for Biologics Evaluation and Research (CBER) May 2023; ICH-Safety

 

Unlock Answers to Critical Questions for Your AAV-Based Studies.

 

AAV_based_research_critical_questions

 

Elevate Your Studies with RNAscope and Unlock a Deeper Understanding of Your AAV Therapeutic and Transgene Expression.

Morphology-Based Detection: Visualize AAV vector biodistribution and transgene levels at the single-cell level in intact fixed tissue.

Targeted Probes: RNAscope probes can be designed to target unique regions within the promoter of the AAV vector DNA or the transgene mRNA of the viral construct.

Visualize and Quantify: Measure percentage of AAV positive cells for vector and transgene expression.

Codon Optimized Expression Analysis: Distinguish transgene from endogenous sequences, at the single nucleotide level.

 

Representation of the Gene Therapy Probe Design Strategy

RNAscope probes can be designed to target unique regions within the promotor of the AAV vector DNA or the transgene mRNA of the viral construct.

 

AAV-infographic-Gene-Therapy-Page

Why RNAscope?

RNAscope enables tissue-based analysis of viral tropism, transduction efficiency, and persistence over time. Researchers also evaluate dosing, safety and efficacy, and functional markers using RNAscope ISH.

  • Characterize tissue biodistribution, cellular tropism, and transduction efficiency of your vector at single-cell resolution in conjunction with cell-type specific markers.

  • Measure abundance of AAV+ cells in target tissues and track vector persistence over time.

  • Quantify RNA expression of any vector cargo including sequence or codon-optimized human transgenes, CRISPR/Cas9, guide RNAs, or other regulatory non-coding RNAs.

  • Demonstrate therapeutic efficacy within vector transduced cells and tissues.

  • Easily Scale from small animal models to non-human primates with the capability to easily distinguish human transgenes from homologous host transcripts.

Single Cell Resolution
Simple Assay Workflow
Ready to use Probes
Professional Assay Services

 

Recorded Webinar

Julio D Nieves, Associate Director, Imaging, Adverum presents:

2023 ASGCT - ' Using BaseScope Assay for Evaluation of Ocular Biodistribution of Gene Therapy Products' - Webinar 

Watch Video

 

 

Fig 1. Identification of specific cells transduced by AAV-GFP following subretinal injection using the RNAscope 2.5 HD Duplex assay to simultaneously detect the CB promoter DNA sequence of the AAV vector (green) and the GFP transgene mRNA (red). Staining was observed in almost all of the retinal layers (with the exception of the choroid) in the transduced region, but no staining was observed in the non-transduced naïve region.

 

 

BaseScope staining allows visualization and quantification of transgene expression (red arrow) and AAV vector (green arrow) presence in treated liver samples

Fig 2. BaseScope staining allows visualization and quantification of transgene expression (red arrow) and AAV vector (green arrow) presence in treated liver samples

Products

Probes/Targets

Catalog Probes (Ex: CMV, CBA, WPRE, etc.)

Search Catalog Control & Target Probes

If your gene of interest in not listed in our catalog, ACD can design and manufacture new in situ hybridization probes for you, To order or get more info on Made-to-Order New Targets Probes, please fill in the form below and an ACD Account Executive will contact you.

Made-to-Order
Read Less

Professional Assay Services

  • Unparalleled expertise in RNAscope and BaseScope ISH
  • High capacity and high throughput, delivering more than 10,000 slides per year
  • Supporting dozens of gene therapy companies for research studies enabling pre-IND submission
  • Team of specialists perform quantitative image analysis using HALO™ Software (Indica Labs)
  • Board-certified pathologist review
  • Actionable results delivered in weeks rather than months
Learn More
Read Less

Resources

Recorded Webinar

Visual detection and quantification of AAV and LV vector biodistribution and transgene expression in preclinical animal models with RNAscope and BaseScope™ in situ hybridization.

 

Application Note

Application note 'Tissue Biodistribution of AAV-based gene therapy with the RNAscope™ assay'

 

 

Flyer

PowerfulVisualization_Toolsfor_GeneTherapy

Accelerate Gene Therapy Development with Powerful Visualization Tools for Biodistribution and Functional Analysis

 

 

Brochure

Accelerate-GeneTherapy-Development

Accelerate Gene Therapy Development with RNA and Vector DNA Visualization Tools for Biodistribution and Safety Analysis

 

 

Publications

Read Less

 

Have questions?

Our dedicated team can reach out to you and see how ACD can help.

Ask a question

Custom Projects?

Gain exclusive access to non-commercialized products

Request a consult

X
Contact Us

Complete one of the three forms below and we will get back to you.

For Quote Requests, please provide more details in the Contact Sales form below

Advanced Cell Diagnostics

Our new headquarters office starting May 2016:

7707 Gateway Blvd.  
Newark, CA 94560
Toll Free: 1 (877) 576-3636
Phone: (510) 576-8800
Fax: (510) 576-8798

 

Bio-Techne

19 Barton Lane  
Abingdon Science Park
Abingdon
OX14 3NB
United Kingdom
Phone 2: +44 1235 529449
Fax: +44 1235 533420

 

Advanced Cell Diagnostics China

20F, Tower 3,
Raffles City Changning Office,
1193 Changning Road, Shanghai 200051

021-52293200
info.cn@bio-techne.com
Web: www.acdbio.com/cn

For general information: Info.ACD@bio-techne.com
For place an order: order.ACD@bio-techne.com
For product support: support.ACD@bio-techne.com
For career opportunities: hr.ACD@bio-techne.com